Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting neurological and cardiovascular diseases. Its structure supports the construction of complex alkaloids and enzyme inhibitors. The tert-butoxycarbonyl (Boc) group allows for selective protection of amines during peptide coupling and multistep syntheses. Commonly employed in asymmetric synthesis due to the stereogenic center, enabling high enantioselectivity in drug candidates. Also utilized in the preparation of protease inhibitors and receptor agonists/antagonists where precise spatial orientation of functional groups is critical.